As of 2025-06-19, the Intrinsic Value of Laurus Labs Ltd (LAURUSLABS.NS) is 89.83 INR. This LAURUSLABS.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 664.35 INR, the upside of Laurus Labs Ltd is -86.50%.
The range of the Intrinsic Value is 67.19 - 124.79 INR
Based on its market price of 664.35 INR and our intrinsic valuation, Laurus Labs Ltd (LAURUSLABS.NS) is overvalued by 86.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 67.19 - 124.79 | 89.83 | -86.5% |
| DCF (Growth 10y) | 141.83 - 234.02 | 178.33 | -73.2% |
| DCF (EBITDA 5y) | 570.44 - 741.49 | 642.47 | -3.3% |
| DCF (EBITDA 10y) | 603.19 - 846.78 | 706.39 | 6.3% |
| Fair Value | 165.99 - 165.99 | 165.99 | -75.01% |
| P/E | 231.06 - 324.24 | 270.91 | -59.2% |
| EV/EBITDA | 356.64 - 605.15 | 467.88 | -29.6% |
| EPV | 39.06 - 54.22 | 46.64 | -93.0% |
| DDM - Stable | 37.62 - 74.46 | 56.04 | -91.6% |
| DDM - Multi | 111.51 - 171.76 | 135.26 | -79.6% |
| Market Cap (mil) | 358,443.40 |
| Beta | 1.22 |
| Outstanding shares (mil) | 539.54 |
| Enterprise Value (mil) | 384,638.60 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.19% |
| Cost of Debt | 9.23% |
| WACC | 13.69% |